SERAPHINA Study: Nab-Paclitaxel Benefits in HER2-Negative Cancer
The recent commentary by K. Altundag sheds light on the SERAPHINA study, which offers crucial insights into nab-paclitaxel’s role in ...
Tag: HER2-negative breast cancer treatment
Palbociclib vs. Ribociclib: Indian Breast Cancer Study
In a groundbreaking study emerging from India, researchers have conducted a meticulous head-to-head comparison of two prominent cyclin-dependent kinase 4/6 ...
Official BRACELET-1 Trial Shows Pelareorep Combined with Paclitaxel Holds Promise in HR+ HER2- Metastatic Breast Cancer
In a groundbreaking development within the field of metastatic breast cancer treatment, the results of the BRACELET-01 (PrECOG 0113) trial ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!